SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis
NVS 123.84+1.0%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack Hartmann who wrote (266)3/4/2000 12:19:00 AM
From: Jack Hartmann  Read Replies (1) of 296
 
Swiss Business Briefs: Novartis Seeking Glaucoma Drug OK
March 3, 2000
Dow Jones Newswires

ZURICH -- Novartis AG (Z.NOV) said its Ciba Vision eye care unit filed applications with U.S. and E.U. regulators for permission to market Rescula, a treatment for glaucoma, which affects 9 million people in those markets.

Looks good.
Jack
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News